Phase II trial of bevacizumab with carboplatin and dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer

Fleming, Nicole

192
Phase II trial of bevacizumab with carboplatin and dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer

Saturday, March 28, 2015: 9:55 AM

Salon C-D (Hilton Chicago)

N. D. Fleming¹, R. L. Coleman¹, C. S. Tung², M. F. Munsell¹ and A. K. Sood¹
¹The University of Texas MD Anderson Cancer Center, Houston, TX, ²Baylor College of Medicine, Houston, TX

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

192
Phase II trial of bevacizumab with carboplatin and dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer

192 Phase II trial of bevacizumab with carboplatin and dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer

192
Phase II trial of bevacizumab with carboplatin and dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer